Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin
Authors:
- 14 December 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (24) , 10362-10370
Abstract
The p53 tumor suppressor plays a major protective role in tumor prevention by coordinating changes in gene expression that lead to the elimination of cancer cells. Mage-A proteins comprise a family of metastasis-associated transcriptional regulators that potently inhibit p53 function. Here, we show that Mage-A interacts with 3 distinct peptides each of which is located within the DNA binding surface of the core domain of p53 and encompasses amino acids that are critical for site-specific DNA binding. These data suggest that Mage-A may block the association of p53 with its cognate sites in chromatin. Consistent with this idea, silencing of Mage-A expression leads to upregulation of several p53-responsive genes in a p53-dependent manner and stimulates by several fold the interaction of p53 with the p21, MDM2, and PUMA promoters. Notably, these effects can occur in the absence of genotoxic stress, leading in a p53-dependent manner, to cell-cycle delay and increased cell death. These data reveal a novel mechanism by which Mage-A proteins may suppress the p53 transcriptional program during tumor development and highlight the p53/Mage-A interaction as a prospective therapeutic target. Cancer Res; 70(24); 10362–70. ©2010 AACR.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Posttranslational Modification of p53: Cooperative Integrators of FunctionCold Spring Harbor Perspectives in Biology, 2009
- Acetylation Is Indispensable for p53 ActivationCell, 2008
- Mechanisms of regulatory diversity within the p53 transcriptional networkOncogene, 2008
- p53 in health and diseaseNature Reviews Molecular Cell Biology, 2007
- Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressorGenes & Development, 2006
- MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agentsProceedings of the National Academy of Sciences, 2006
- Levels of HdmX Expression Dictate the Sensitivity of Normal and Transformed Cells to Nutlin-3Cancer Research, 2006
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995
- Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumoursEuropean Journal of Cancer, 1993